Course: Relapsed/Refractory Follicular Lymphoma: Insights for the Academic and Community Clinician
CME Credits: 1.00
Released: 2025-02-06
Patient-centered care is required for the effective management of relapsed/refractory follicular lymphoma (R/R FL). As new cases of R/R FL increase with limited management options, there is a need for more biologically active agents that have demonstrated clinically relevant improvements in survival. With recent advances in treatments and in ongoing clinical studies, clinicians must be updated on developments related to novel agents and their associated clinical evidence to ensure they are prepared to utilize novel therapies to appropriately build effective treatment regimens in the future. One academic and one community-based hematologist will discuss current and future strategies for treating people with R/R FL as well as challenges/barriers to the implementation of novel therapies in the community setting.
View Full Course